RT Journal Article
SR Electronic
T1 Pembrolizumab Monotherapy Is Active in Metastatic Prostate Cancer
JF Cancer Discovery
JO Cancer Discov
FD American Association for Cancer Research
SP 15
OP 15
DO 10.1158/2159-8290.CD-RW2019-181
VO 10
IS 1
YR 2020
UL http://cancerdiscovery.aacrjournals.org/content/10/1/15.1.abstract
AB In patients with metastatic castration-resistant prostate cancer, pembrolizumab showed efficacy.